Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia

Blood

Volumn 88, Issue 12, 1996, Pages 4493-4499

  Wodnar Filipowicz, Aleksandra ^a   Lyman, Stewart D ^b   Gratwohl, Alois ^b   Tichelli, André ^b   Speck, Bruno ^b   Nissen, Catherine ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LYMPHOCYTE ANTIBODY;

APLASTIC ANEMIA; ARTICLE; BONE MARROW APLASIA; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0029856349     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.12.4493.bloodjournal88124493     Document Type: Article

References (34)

1. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
2. Young NS: Aplastic anaemia. Lancet 346:228, 1995
3. Nissen-Druey C: Pathophysiology of aplastic anemia. Semin Hematol 28:313, 1991
4. Maciejewski JP, Andersen S, Katevas P. Young NS: Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Hematol 87:227, 1994
5. Manz CY, Nissen C. Wodnar-Filipowicz A: Deficiency of CD34'c-kit' and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment. Am J Hematol 52:264, 1996
6. Nissen C. Gratwohl A, Speck B: Management of aplastic anemia. Eur J Hematol 46:193, 1991
7. Young NS, Barrett AJ: The treatment of severe acquired aplastic anemia. Blood 85:3367, 1995
8. Lyman SD, James L, Vanden BT, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FF, Maraskovsky E, Farrach F, Foxworthe D, Williams DE, Beckmann MP: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 75:1157, 1993
9. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Keiner G, Namikawa R, Rennick D, Roncarolo M-G, Zlotnik A. Rosnet O, Dubreuil P, Birnbaum D, Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
10. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR: A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143, 1991
11. Rosnet O, Marchetto S, deLapeyriere O, Birnbaum D: Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/ CSF1R family. Oncogene 6:1641, 1991
12. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994
13. Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P, Witte L, Burrow C, Ratajczak MZ, Gewirtz AM, Civin CI: STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459, 1994
14. Hudak S, Hunte B, Culpepper J, Mennon S, Hannum C, Thompson-Snipes L, Rennick D: Flt3/flk2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 85:2747, 1995
15. Muench MO, Roncarolo MG, Menon S, Xu Y, Kastelein R, Zurawski S, Hannum CH, Culpepper J, Lee F, Namikawa R: Flk-2/Flt-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 85:963, 1995
16. Broxmeyer HE, Lu L, Cooper S, Ruggieri L, Li ZH, Lyman S: Flt3 ligand stimulates/costimulates the growth of myeloid stem/ progenitor cells. Exp Hematol 23:1121, 1995
17. Lyman SD, James L, Escobar S, Downey H, de Vries P, Brasel K, Stocking K, Beckman MP, Copeland NG, Cleveland LS, Jenkins NA, Belmont JW, Davison BL: Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs. Oncogene 10:149, 1995
18. Fleischman RA: From white spots to stem cells: The role of the kit receptor in mammalian development. Trends Genet 9:285, 1993
19. Lyman SD, Seaberg M, Hanna R, Zappone J, Brasel K, Abkowitz JL, Prchal J, Schultz J, Shahidi NT: Flt3 ligand plasma/serum levels are low in normal individuals and are highly elevated in patients with Fanconi anemia and acquired aplastic anemias. Blood 86:4091, 1995
20. Camitta BM, Storb R, Thomas EB: Aplastic anemia. N Engl J Med 306:645, 1982
21. Wodnar-Filipowicz A, Tichelli A, Zsebo KM, Speck B, Nissen C: Stem cell factor stimulates the in vitro growth of bone marrow cells from aplastic anemia patients. Blood 79:3196, 1992
22. Bacigalupo A, Podesta M, Mingari MC, Moretta L, van Lint MT, Marmont A: Immune suppression of hematopoiesis in aplastic anemia: Activity of T- g lymphocytes. J Immunol 125:1449, 1981
23. Nissen C, Wodnar-Filipowicz A, Slanicka Krieger M, Gratwohl A, Tichelli A, Speck B: Persistent growth impairement of bone marrow stroma after antilymphocyte globulin treatment for severe severe aplastic anemia and its association with relapse. Eur J Hematol 55:255, 1995
24. Langley KE, Bennett LG. Wypych J, Yancik SA, Liu XD, Westcott KR, G. CD, Smith KA, Zsebo KM: Soluble stem cell factor in human serum. Blood 81:656, 1993
25. Wodnar-Filipowicz A, Yancik S, Moser Y, dalle Carbonare V, Gratwohl A, Tichelli A, Speck B, Nissen C: Levels of soluble stem cell factor in serum of patients with aplastic anemia. Blood 81:3259, 1993
26. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
27. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147, 1995
28. Abkowitz JL, Hume H, Yancik SA, Bennett LG, Matsumoto AM: Stem cell factor serum levels may not be clinically relevant. Blood 87:4017, 1996
29. Schrezenmeier H, Noe G, Raghavachar A, Rich IN, Heimpel H, Kubanek B: Serum erythropoietin and serum transferrin receptor levels in aplastic anemia. Br J Hematol 88:286, 1994
30. Emmons RVB, Reid DM, Cohen RL, Meng G, Young NS, Dunbar CE, Shulman NR: Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068, 1996
31. Kaushansky K: Thrombopoietin: The primary regulator of platelet production. Blood 86:419, 1995
32. Zeigler FC, Bennett BD, Jordan CT, Spencer SD, Baumhueter S, Carrol KJ, Hooley J, Bauer K, Matthews W: Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 84:2422, 1994
33. McKenna HJ, de Vries P, Brasel K, Lyman SD, Williams DE: Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells. Blood 86:3413, 1995
34. Porter DL, Goldberg MA: Physiology of erythropoietin production. Semin Hematol 31:112, 1994